Bank of America Securities analyst Graham Parry maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) yesterday and set a ...

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...

GSK has turned to Brooke Shields to get the message out about shingles vaccination. | GSK has turned to Brooke Shields to get ...

After an initial defeat against the biggest barrier to mRNA flu vaccines—namely, B strains of influenza—GSK has returned with a reformulated candidate that has ...

GlaxoSmithKline’s (GSK ... part of the UnitedHealthcare group, America’s biggest health insurer. Witty was already on the company’s board, but will now step down from this position to ...

Latin America Cargo City is a single brand of Corporación ... Lacalle Pou “welcomed GSK's announcement of the opening of one of its three new regional vaccine distribution centers in Uruguay”.

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced the ...

GameStop announced an offering of up to 20 million shares. In Q2, GameStop reported revenue of $798.3 million, compared to $1 ...

Analyst Graham Parry from Bank of America Securities maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) and keeping the ...

GSK plc (LSE/NYSE: GSK) today announced positive topline data from the phase 3 trial in adults 50 years and older evaluating the immunogenicity, reactogenicity and safety of AREXVY (Respiratory ...

The Bank of England could cut interest rates to 2.75pc next year, analysts have suggested, amid growing confidence that the ...

Fulcrum Therapeutics (FULC) stock falls 70% as lead asset, losmapimod licensed from GSK (GSK) fails in a Phase 3 trial against a rare muscle disorder. Read more here.